| PWR |
Report |
Q2 2026 adjusted EPS |
BEAT |
pred ~$3.38 vs. cons $3.27 |
MEDIUM |
| PWR |
Report |
Q2 2026 revenue |
BEAT |
pred ~$8.68B vs. cons $8.55B |
MEDIUM |
| PWR |
Report |
Q2 2026 total backlog |
BEAT |
pred ~$51.3B vs. cons $50.4B |
MEDIUM |
| PWR |
Guide |
Adjusted EPS guidance |
BETTER |
guide ~$14.35 midpoint vs. cons $14.03 (FY 2026) |
MEDIUM |
| PWR |
Guide |
Revenue guidance |
BETTER |
guide ~$35.40B midpoint vs. cons $35.01B (FY 2026) |
MEDIUM |
| PWR |
Guide |
Free cash flow guidance |
UNCHANGED |
guide ~$1.80B midpoint vs. cons $1.93B (FY 2026) |
MEDIUM |
| PWR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+5.5% |
— |
MEDIUM |
| PWR |
Return |
5-day cumulative residual |
+7.2% (FOLLOW-THROUGH) |
The predicted FY 2026 adjusted-EPS guide of ~$14.35 vs. consensus $14.03 implies approximately $8.29 of second-half EPS after predicted first-half EPS of $6.06, versus roughly $8.08 embedded in consensus; that positive out-period math should drive estimate revisions beyond the initial beat. |
MEDIUM |